CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo-Reference-Cited by-同舟云学术

CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

Published:2020-04-06 Issue:5 Volume:130 Page:2435-2450
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Alajati Abdullah,D’Ambrosio Mariantonietta,Troiani Martina,Mosole Simone,Pellegrini Laura^ORCID,Chen Jingjing^ORCID,Revandkar Ajinkya,Bolis Marco^ORCID,Theurillat Jean-Philippe,Guccini Ilaria^ORCID,Losa Marco,Calcinotto Arianna,De Bernardis Gaston,Pasquini Emiliano,D’Antuono Rocco^ORCID,Sharp Adam,Figueiredo Ines,Nava Rodrigues Daniel,Welti Jonathan,Gil Veronica,Yuan Wei,Vlajnic Tatjana,Bubendorf Lukas^ORCID,Chiorino Giovanna^ORCID,Gnetti Letizia,Torrano Verónica,Carracedo Arkaitz^ORCID,Camplese Laura,Hirabayashi Susumu,Canato Elena^ORCID,Pasut Gianfranco^ORCID,Montopoli Monica,Rüschoff Jan Hendrik^ORCID,Wild Peter,Moch Holger,De Bono Johann^ORCID,Alimonti Andrea

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/131133/files/pdf

Reference57 articles.

1. Global cancer statistics, 2012

2. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

3. Mechanisms of resistance in castration-resistant prostate cancer (CRPC);Chandrasekar;Transl Androl Urol,2015

4. Molecular and cellular mechanisms of castration resistant prostate cancer;Huang;Oncol Lett,2018

5. Integrative Genomic Profiling of Human Prostate Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses;Cell Communication and Signaling;2024-01-19

2. Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis;Circulation Research;2023-10-27

3. Anti‐HER2 Super Stealth Immunoliposomes for Targeted‐Chemotherapy;Advanced Healthcare Materials;2023-08-30

4. The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells;Nature Cancer;2023-07-17

5. Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment;Molecular Oncology;2023-04-20